Incannex Net Income Applicable To Common Shares from 2010 to 2026
| IXHL Stock | USD 0.28 0.01 3.45% |
Net Loss | First Reported 2010-12-31 | Previous Quarter -18 M | Current Value -17.1 M | Quarterly Volatility 7.5 M |
Check Incannex Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Incannex Healthcare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 486.7 K, Interest Expense of 365.9 K or Gross Profit of 86.7 K, as well as many indicators such as Price To Sales Ratio of 94.41, Dividend Yield of 0.0 or PTB Ratio of 0.67. Incannex financial statements analysis is a perfect complement when working with Incannex Healthcare Valuation or Volatility modules.
Incannex | Net Income Applicable To Common Shares | Build AI portfolio with Incannex Stock |
Historical Net Income Applicable To Common Shares data for Incannex Healthcare serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether Incannex Healthcare Ltd represents a compelling investment opportunity.
Latest Incannex Healthcare's Net Income Applicable To Common Shares Growth Pattern
Below is the plot of the Net Income Applicable To Common Shares of Incannex Healthcare Ltd over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. Incannex Healthcare's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Incannex Healthcare's overall financial position and show how it may be relating to other accounts over time.
| Net Income Applicable To Common Shares | 10 Years Trend |
|
Net Income Applicable To Common Shares |
| Timeline |
Incannex Net Income Applicable To Common Shares Regression Statistics
| Arithmetic Mean | (8,957,616) | |
| Coefficient Of Variation | (83.69) | |
| Mean Deviation | 6,891,317 | |
| Median | (2,947,991) | |
| Standard Deviation | 7,496,197 | |
| Sample Variance | 56.2T | |
| Range | 17.3M | |
| R-Value | (0.87) | |
| Mean Square Error | 14.3T | |
| R-Squared | 0.76 | |
| Slope | (1,294,735) | |
| Total Sum of Squares | 899.1T |
Incannex Net Income Applicable To Common Shares History
About Incannex Healthcare Financial Statements
Incannex Healthcare investors utilize fundamental indicators, such as Net Income Applicable To Common Shares, to predict how Incannex Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Loss | -18 M | -17.1 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of Incannex Healthcare Correlation against competitors. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Incannex Healthcare. Market participants price Incannex higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Incannex Healthcare assessment requires weighing all these inputs, though not all factors influence outcomes equally.
The market value of Incannex Healthcare is measured differently than its book value, which is the value of Incannex that is recorded on the company's balance sheet. Investors also form their own opinion of Incannex Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Incannex Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Incannex Healthcare's market value can be influenced by many factors that don't directly affect Incannex Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Incannex Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Incannex Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Incannex Healthcare's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.